{"id":"W7117291323","doi":"10.1016/j.iotech.2025.101225","title":"141P Clinical study of camrelizumab combined with SOX in adjuvant therapy for gastric or gastroesophageal junction adenocarcinoma: Interim report","year":2025,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Jonsson Comprehensive Cancer Center; University of Colorado Denver; University of Pittsburgh; Medical Center, University of Pittsburgh; Vanderbilt University Medical Center; McGill University Health Centre; McGill University; Northwestern University; University of Texas MD Anderson Cancer Center; School of Medicine, Stanford University; Vanderbilt University; Moffitt Cancer Center; Ohio State University","keywords":"Clinical study; Gastroesophageal Junction; Adjuvant therapy; Clinical trial; Adjuvant; Interim; Interim analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781934,0.0005135106,0.001036566,0.0002074457,0.000283143,0.001031106,0.0003792896,0.001037451,0.007354795],"category_scores_gemma":[0.001564445,0.0001976558,0.001482403,0.0003821696,0.000333961,0.0005933105,0.0003419626,0.001974679,0.001752478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006027176,"about_ca_system_score_gemma":0.001273539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004529955,"about_ca_topic_score_gemma":0.0008599107,"domain_scores_codex":[0.9994585,0.0002282483,0.00005251052,0.0000701391,0.00009531769,0.00009527407],"domain_scores_gemma":[0.9992862,0.0001412055,0.0001315334,0.00007091245,0.0001029651,0.0002672061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5191137,0.01839335,0.02489849,0.004677134,0.005263098,0.001753693,0.0002684153,0.001556699,0.01969842,0.0009477656,0.03584139,0.3675878],"study_design_scores_gemma":[0.3296034,0.5090404,0.06242285,0.000868861,0.004361531,0.001959591,0.000136478,0.00136617,0.007970582,0.0009295428,0.08127813,0.00006252715],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8913063,0.03660703,0.002394308,0.007749299,0.002078155,0.009855422,0.01362517,0.0002675453,0.03611667],"genre_scores_gemma":[0.9459232,0.01352229,0.003048116,0.006043219,0.001513534,0.005007355,0.01312401,0.00005312608,0.01176522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007354795,"threshold_uncertainty_score":0.02460426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03616686054081508,"score_gpt":0.384055794376691,"score_spread":0.3478889338358759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}